TBPH (Theravance Biopharma) Utang jangka cendhak marang modal
The global distribution of respiratory treatments relies on established supply chains, ensuring medication availability in pharmacies. The price trend on GURU.Markets, where the indicator equals 0.03, links logistics to partnerships with industry behemoths for joint product promotion. Meanwhile, steady demand for lung treatments ensures a stable cash flow, supporting the operational activity of Theravance Biopharma (TBPH).
Rincian analitis perusahaan Theravance Biopharma
- kuotasi lan prakiraan analis:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Theravance Biopharma|TBPH - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Theravance Biopharma, Inc.|TBPH - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Theravance Biopharma Inc|TBPH - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Theravance Biopharma|Rasio cepet theravance.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Pambiji fundamental:TBPH Theravance
Through partnerships with pharma giants and the receipt of royalties, Theravance Biopharma (TBPH) minimizes operating expenses, which directly impacts its short-term financial leverage ratio. This metric compares liabilities with maturities of up to one year against total equity to measure immediate liquidity and resilience to cash flow gaps, allowing investors to assess the balance between financial security and the efficiency of borrowed fund utilization.
Pesaing Theravance Biopharma (TBPH)
Utang jangka cendhak marang modal HLN|KVUE (Kenvue Health) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal VRNA (Verona Pharma plc)|Utang jangka cendhak marang modal jyongbio.com MENS|LGND - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal glpg.com|Rasio utang jangka cendhak marang ekuitas ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Amphastar AMPH|Pacira Corp (PCRX) - Kewajiban jangka cendhak marang modal|SPRY: Rasio utang jangka cendhak marang ekuitas|aquestive.com - Rasio silihan jangka cendhak marang modal|SCPH: Utang jangka cendhak marang modal|Tectonic Therapeutic - Rasio tanggungan utang jangka cendhak marang modal|TNXP (Tonix Pharmaceuticals Inc.) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal SXT China SXTC|Utang jangka cendhak marang ekuitas Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Rasio tanggungan utang jangka cendhak marang modal|eXoZymes - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal ORMP (Oramed)|Entera Bio Corp - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal HYFT (MindWalk Therapeutics)|ABVC: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal cumberlandpharma.com (CPIX)|Utang jangka cendhak marang ekuitas Quantum BioPharma|FGEN: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal TELO|Utang jangka cendhak marang modal ranitherapeutics.com (RANI)|Synergy CHC - Rasio utang jangka cendhak marang ekuitas|Rallybio Corp - Utang jangka cendhak marang ekuitas|Lexaria - Utang jangka cendhak marang modal|PULM - Utang jangka cendhak marang modal|ftzy.com.cn (PTHL) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal APM|LYRA (Lyra Therapeutics, Inc.) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas impactbiomedinc.com (IBO)|Utang jangka cendhak marang modal TNFA|YCBD - Kewajiban jangka cendhak marang modal|PainReform Limited - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal CYTO|Lipella Pharmaceuticals - Utang jangka cendhak marang modal|OPTN: Utang jangka cendhak marang ekuitas|PIRS: Utang jangka cendhak marang modal|PROC - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Petros|Kewajiban jangka cendhak marang modal Qilian International Corp QLI|Utang jangka cendhak marang ekuitas Acelyrin, Inc. (SLRN)|TFFP: Kewajiban jangka cendhak marang ekuitas